|
|
||||||||
The Journal of Immunology, Vol 158, Issue 2 977-983, Copyright © 1997 by American Association of Immunologists
ARTICLES |
AR Hayward, J Levy, F Facchetti, L Notarangelo, HD Ochs, A Etzioni, JY Bonnefoy, M Cosyns and A Weinberg
Department of Pediatrics, University of Colorado, Denver 80262, USA.
We report an association between X-linked immunodeficiency with hyper- IgM (XHIM) and carcinomas affecting the liver, pancreas, biliary tree, and associated neuroectodermal endocrine cells. The tumors were fatal in eight of nine cases and in most instances were preceded by chronic cholangiopathy and/or cirrhosis. An additional group of subjects with XHIM had chronic inflammation of the liver or bile ducts but no malignancy. Many patients with XHIM were infected with cryptosporidia. CD40 is normally expressed on regenerating or inflammed bile duct epithelium. A CD40+ hepatocellular carcinoma cell line, HepG2, susceptible to cryptosporidia and CMV infection became resistant when cell surface CD40 was cross-linked by a CD40 ligand fusion protein. Apoptosis was triggered in HepG2 cells if protein synthesis was blocked by cycloheximide or if the cells were infected by cryptosporidia. Ligation of CD40 on biliary epithelium may contribute to defense against infection by intracellular pathogens. We propose that the CD40 ligand mutations that cause XHIM deprive the biliary epithelium of one line of defense against intracellular pathogens and that malignant transformation in the biliary tree follows chronic infection or inflammation. The resulting tumors may then progress without check by an effective immune response. Patients with XHIM who have abnormal liver function tests should be considered at increased risk for cholangiopathy or malignancy.
This article has been cited by other articles:
![]() |
A. Moschonas, M. Kouraki, P. G. Knox, E. Thymiakou, D. Kardassis, and A. G. Eliopoulos CD40 Induces Antigen Transporter and Immunoproteasome Gene Expression in Carcinomas via the Coordinated Action of NF-{kappa}B and of NF-{kappa}B-Mediated De Novo Synthesis of IRF-1 Mol. Cell. Biol., October 15, 2008; 28(20): 6208 - 6222. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pantenburg, S. M. Dann, H.-C. Wang, P. Robinson, A. Castellanos-Gonzalez, D. E. Lewis, and A. C. White Jr. Intestinal Immune Response to Human Cryptosporidium sp. Infection Infect. Immun., January 1, 2008; 76(1): 23 - 29. [Full Text] [PDF] |
||||
![]() |
Y. Tsuji, K. Imai, Y. Morinishi, K. Kogawa, M. Morino, and S. Nonoyama Successful unrelated cord blood transplantation for a patient with CD40 ligand deficiency Haematologica, December 1, 2007; 92(12): 1727 - 1728. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lopez-Granados, S. T. Temmerman, L. Wu, J. C. Reynolds, D. Follmann, S. Liu, D. L. Nelson, F. Rauch, and A. Jain Osteopenia in X-linked hyper-IgM syndrome reveals a regulatory role for CD40 ligand in osteoclastogenesis PNAS, March 20, 2007; 104(12): 5056 - 5061. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. O'Hara, A. J. Small, J. B. Nelson, A. D. Badley, X.-M. Chen, G. J. Gores, and N. F. LaRusso The Human Immunodeficiency Virus Type 1 Tat Protein Enhances Cryptosporidium parvum-Induced Apoptosis in Cholangiocytes via a Fas Ligand-Dependent Mechanism Infect. Immun., February 1, 2007; 75(2): 684 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Baishanbo, G. Gargala, C. Duclos, A. Francois, J.-F. Rossignol, J. J. Ballet, and L. Favennec Efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed gerbil model J. Antimicrob. Chemother., February 1, 2006; 57(2): 353 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Law, K. A. Gordon, J. Collier, K. Klussman, J. A. McEarchern, C. G. Cerveny, B. J. Mixan, W. P. Lee, Z. Lin, P. Valdez, et al. Preclinical Antilymphoma Activity of a Humanized Anti-CD40 Monoclonal Antibody, SGN-40 Cancer Res., September 15, 2005; 65(18): 8331 - 8338. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Hill, S. J. Youde, S. Man, G. R. Teale, A. J. Baxendale, A. Hislop, C. C. Davies, D. M. Luesley, A. M. Blom, A. B. Rickinson, et al. Activation of CD40 in Cervical Carcinoma Cells Facilitates CTL Responses and Augments Chemotherapy-Induced Apoptosis J. Immunol., January 1, 2005; 174(1): 41 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Lim and K. S.J. Elenitoba-Johnson The Molecular Pathology of Primary Immunodeficiencies J. Mol. Diagn., May 1, 2004; 6(2): 59 - 83. [Full Text] [PDF] |
||||
![]() |
M. A. G. Morales, R. Mele, A. Ludovisi, F. Bruschi, F. Tosini, and E. Pozio Cryptosporidium parvum-Specific CD4 Th1 Cells from Sensitized Donors Responding to Both Fractionated and Recombinant Antigenic Proteins Infect. Immun., March 1, 2004; 72(3): 1306 - 1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Jacobsohn, K. M. Emerick, P. Scholl, H. Melin-Aldana, M. O'Gorman, R. Duerst, and M. Kletzel Nonmyeloablative Hematopoietic Stem Cell Transplant for X-Linked Hyper-Immunoglobulin M Syndrome With Cholangiopathy Pediatrics, February 1, 2004; 113(2): e122 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Gennery, K. Khawaja, P. Veys, R. G. M. Bredius, L. D. Notarangelo, E. Mazzolari, A. Fischer, P. Landais, M. Cavazzana-Calvo, W. Friedrich, et al. Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002 Blood, February 1, 2004; 103(3): 1152 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Davies, J. Mason, M. J. O. Wakelam, L. S. Young, and A. G. Eliopoulos Inhibition of Phosphatidylinositol 3-Kinase- and ERK MAPK-regulated Protein Synthesis Reveals the Pro-apoptotic Properties of CD40 Ligation in Carcinoma Cells J. Biol. Chem., January 9, 2004; 279(2): 1010 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fontana, D. Moratto, S. Mangal, M. De Francesco, W. Vermi, S. Ferrari, F. Facchetti, N. Kutukculer, C. Fiorini, M. Duse, et al. Functional defects of dendritic cells in patients with CD40 deficiency Blood, December 1, 2003; 102(12): 4099 - 4106. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Drewe, A. M. Zaitoun, D. A. Walker, and S. Mukherjee Case 11-2003: Ulcerative Colitis and Primary Sclerosing Cholangitis in a 14-Year-Old Boy N. Engl. J. Med., October 9, 2003; 349(15): 1482 - 1482. [Full Text] [PDF] |
||||
![]() |
K. Eshima, Y. Choi, and R. A. Flavell CD154-CD40-independent up-regulation of B7-2 on splenic antigen-presenting cells and efficient T cell priming by staphylococcal enterotoxin A Int. Immunol., July 1, 2003; 15(7): 817 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Schrum, I. Marriott, B. R. Butler, E. K. Thomas, M. C. Hudson, and K. L. Bost Functional CD40 Expression Induced following Bacterial Infection of Mouse and Human Osteoblasts Infect. Immun., March 1, 2003; 71(3): 1209 - 1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Cooper, L. L. Lanier, M. E. Conley, and J. M. Puck Immunodeficiency Disorders Hematology, January 1, 2003; 2003(1): 314 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Bugajska, N. T. Georgopoulos, J. Southgate, P. W. M. Johnson, P. Graber, J. Gordon, P. J. Selby, and L. K. Trejdosiewicz The Effects of Malignant Transformation on Susceptibility of Human Urothelial Cells to CD40-Mediated Apoptosis J Natl Cancer Inst, September 18, 2002; 94(18): 1381 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Hunter and G. Nichols Epidemiology and Clinical Features of Cryptosporidium Infection in Immunocompromised Patients Clin. Microbiol. Rev., January 1, 2002; 15(1): 145 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. AFFORD, J. AHMED-CHOUDHURY, S. RANDHAWA, C. RUSSELL, J. YOUSTER, H. A. CROSBY, A. ELIOPOULOS, S. G. HUBSCHER, L. S. YOUNG, and D. H. ADAMS CD40 activation-induced, Fas-dependent apoptosis and NF-{kappa}B/AP-1 signaling in human intrahepatic biliary epithelial cells FASEB J, November 1, 2001; 15(13): 2345 - 2354. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Ponnuraj and A. R. Hayward Intact Intestinal mRNAs and Intestinal Epithelial Cell Esterase, But Not Cryptosporidium parvum, Reach Mesenteric Lymph Nodes of Infected Mice J. Immunol., November 1, 2001; 167(9): 5321 - 5328. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rossi, J. Sarkar, and D. Scandella Long-term induction of immune tolerance after blockade of CD40-CD40L interaction in a mouse model of hemophilia A Blood, May 1, 2001; 97(9): 2750 - 2757. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Hayward, M. Cosyns, M. Jones, and E. M. Ponnuraj Marrow-Derived CD40-Positive Cells Are Required for Mice To Clear Cryptosporidium parvum Infection Infect. Immun., March 1, 2001; 69(3): 1630 - 1634. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Eliopoulos, C. Davies, P. G. Knox, N. J. Gallagher, S. C. Afford, D. H. Adams, and L. S. Young CD40 Induces Apoptosis in Carcinoma Cells through Activation of Cytotoxic Ligands of the Tumor Necrosis Factor Superfamily Mol. Cell. Biol., August 1, 2000; 20(15): 5503 - 5515. [Abstract] [Full Text] |
||||
![]() |
J. ATEN, A. ROOS, N. CLAESSEN, E. J. M. SCHILDER-TOL, I. J. M. TEN BERGE, and J. J. WEENING Strong and Selective Glomerular Localization of CD134 Ligand and TNF Receptor-1 in Proliferative Lupus Nephritis J. Am. Soc. Nephrol., August 1, 2000; 11(8): 1426 - 1438. [Abstract] [Full Text] |
||||
![]() |
L. Hocqueloux, J.-M. Molina, and A. Gervais Cholangiocarcinoma and AIDS-Related Sclerosing Cholangitis Ann Intern Med, June 20, 2000; 132(12): 1006 - 1007. [Full Text] [PDF] |
||||
![]() |
K. Lukin, M. Cosyns, T. Mitchell, M. Saffry, and A. Hayward Eradication of Cryptosporidium parvum Infection by Mice with Ovalbumin-Specific T Cells Infect. Immun., May 1, 2000; 68(5): 2663 - 2670. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hadzic, A. Pagliuca, M. Rela, B. Portmann, A. Jones, P. Veys, N. D. Heaton, G. J. Mufti, and G. Mieli-Vergani Correction of the Hyper-IgM Syndrome after Liver and Bone Marrow Transplantation N. Engl. J. Med., February 3, 2000; 342(5): 320 - 324. [Full Text] [PDF] |
||||
![]() |
A. M Jones and H. B Gaspar Immunogenetics: changing the face of immunodeficiency J. Clin. Pathol., January 1, 2000; 53(1): 60 - 65. [Full Text] [PDF] |
||||
![]() |
I. Marriott, E. K. Thomas, and K. L. Bost CD40-CD40 Ligand Interactions Augment Survival of Normal Mice, but Not CD40 Ligand Knockout Mice, Challenged Orally with Salmonella dublin Infect. Immun., October 1, 1999; 67(10): 5253 - 5257. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Shepherd and N. I. Kerkvliet Disruption of CD154:CD40 Blocks Generation of Allograft Immunity Without Affecting APC Activation J. Immunol., September 1, 1999; 163(5): 2470 - 2477. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. de Vries, J. G. Noordzij, E. G. Davies, N. Hartwig, J. J.M. van Dongen, M. J.D. van Tol;, H. D. Ochs, and K. Seyama The 782C right-arrow T (T254M) XHIM Mutation: Lack of a Tight Phenotype-Genotype Relationship Blood, August 15, 1999; 94(4): 1488 - 1490. [Full Text] [PDF] |
||||
![]() |
M. Cosyns, S. Tsirkin, M. Jones, R. Flavell, H. Kikutani, and A. R. Hayward Requirement for CD40-CD40 Ligand Interaction for Elimination of Cryptosporidium parvum from Mice Infect. Immun., February 1, 1998; 66(2): 603 - 607. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |